
Multicancer early detection tests show promise in detecting various cancers early, but challenges remain in their accuracy and integration into healthcare systems.


coremsg

These tests would not replace routine screening but help screen patients with no symptoms or nonspecific signs for cancers for which we could not otherwise screen, says an oncologist.

What Is the Future for Multicancer Early Detection Tests?

the-future-of-multicancer-early-detection-tests


The Future of Multicancer Early Detection Tests


title_rewrite


New multicancer early detection (MCED) tests, such as CanScan, MERCURY, and OncoSeek, have the potential to identify a range of cancers, including those without routine screening options, through a single blood test.


Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.

No Routine Cancer Screening Option? New MCED Tests May Help

new-multicancer-early-detection-tests-show-promise-for-identifying-cancers-lacking-routine-screening-options


New Multicancer Early Detection Tests Show Promise for Identifying Cancers Lacking Routine Screening Options
